The largest database of trusted experimental protocols

30 kda ultrafiltration centrifugal tube

Manufactured by Merck Group
Sourced in United States

The 30-kDa ultrafiltration centrifugal tube is a laboratory equipment designed for the separation and concentration of macromolecules, such as proteins, based on their molecular weight. The tube utilizes a semi-permeable membrane with a molecular weight cutoff of 30 kilodaltons, allowing for the selective filtration of molecules smaller than this threshold while retaining larger molecules during a centrifugation process.

Automatically generated - may contain errors

2 protocols using 30 kda ultrafiltration centrifugal tube

1

Pseudotyped HIV and EBOV Lentivirus Production

Check if the same lab product or an alternative is used in the 5 most similar protocols
A replication incompetent pseudotyped HIV (strain SF162) and HIV pseudotyped with GP1,2 of EBOV expressing the firefly luciferase reporter protein (Fluc) were generated as previously described34 (link). In brief, the lentivirus-based pHIV–ZGP–Fluc construct carrying the EBOV glycoprotein GP gene was generated by the co-transfection of 293T cells with pCDNA3.1–EBOV-ZGP-8A and pSG3.Δenv.cmv.Fluc in a 1:2 ratio, using Lipofectamine 3000 (Invitrogen). After incubation for 48 h, the culture supernatant was centrifuged at 210 × g for 5 min, filtered through a 0.45 μM pore-size filter, and concentrated with a 30-kDa ultrafiltration centrifugal tube (Millipore, Boston, MA, USA). All works involving pseudotyped EBOV were performed in a BSL-2 facility at the National Institutes of Food and Drug Control, Beijing, China.
+ Open protocol
+ Expand
2

Generation of Ebola and Marburg Pseudotyped Viruses

Check if the same lab product or an alternative is used in the 5 most similar protocols
HIV pseudotyped viruses with GP1,2 of EBOV, GP of MARV expressing the firefly luciferase reporter protein (Fluc) were generated as previously described21 (link), 24 (link). In brief, the lentivirus-based pHIV-EBOVGP-Fluc construct carrying the EBOV GP gene, and pHIV-MARVGP-Fluc construct carrying the MARV GP gene were generated by the co-transfection of 293T cells with pCDNA3.1-EBOV-ZGP-8A and pCDNA3.1-MARVGP respectively, together and HIV-1 containing firefly luciferase reporter gene (pSG3.cmv.Fluc) in a 1:2 ratio using Lipofectamine 3000 (Invitrogen). After incubation for 48 h, the culture supernatant was centrifuged at 210 × g for 5 min, filtered through a 0.45 μmol/L pore-size filter, and concentrated with a 30-kDa ultrafiltration centrifugal tube (Millipore, Boston, MA, USA). All works involving pseudotyped virus were performed in a BSL-2 facility at the National Institutes of Food and Drug Control, Beijing, China.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!